Page last updated: 2024-08-23

diltiazem and indocyanine green

diltiazem has been researched along with indocyanine green in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's4 (36.36)18.2507
2000's2 (18.18)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ebihara, A; Hosoda, S; Kumagai, Y; Ohashi, K; Sakamoto, K; Sudo, T; Sugimoto, K; Tateishi, T; Toyo-oka, T; Toyosaki, N1
Klockowski, PM; Lener, ME; Rocci, ML; Sirgo, MA1
Fruncillo, RA; Lener, ME; Rocci, ML; Sirgo, MA; Vlasses, PH1
Fujimura, A; Hosoda, S; Kumagai, Y; Ohashi, K; Sakamoto, K; Sudo, T; Sugimoto, K; Tateishi, T; Toyo-oka, T; Toyosaki, N1
Bursch, W; Mühlbacher, F; Rauhs, R; Roth, E; Steininger, R1
Bauer, LA; Davis, R; Greene, L; Horn, JR; Opheim, K; Stenwall, M1
Joo, EH; Lee, YB1
Chaudry, IH; Jarrar, D; Wang, P1

Reviews

2 review(s) available for diltiazem and indocyanine green

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review).
    International journal of molecular medicine, 1999, Volume: 4, Issue:6

    Topics: Adenosine Triphosphate; Animals; Coloring Agents; Critical Care; Cytokines; Diltiazem; Disease Models, Animal; Gene Expression Regulation; Heat-Shock Proteins; Humans; Indocyanine Green; Kupffer Cells; Lipopolysaccharides; Liver Failure; Liver Function Tests; Magnesium Chloride; Male; MAP Kinase Signaling System; Multiple Organ Failure; NF-kappa B; Nitric Oxide; Pentoxifylline; Randomized Controlled Trials as Topic; Rats; Salvage Therapy; Sepsis; Shock; Shock, Hemorrhagic; Systemic Inflammatory Response Syndrome; Wounds and Injuries

1999

Trials

5 trial(s) available for diltiazem and indocyanine green

ArticleYear
Effects of diltiazem on the pharmacokinetics of nifedipine.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:1

    Topics: Adult; Blood Pressure; Diltiazem; Drug Interactions; Half-Life; Heart Rate; Humans; Indocyanine Green; Kinetics; Male; Nifedipine

1990
Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearances in elderly volunteers.
    Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:4

    Topics: Aged; Aged, 80 and over; Antipyrine; Biomarkers; Calcium Channel Blockers; Diltiazem; Humans; Indocyanine Green; Isradipine; Liver; Liver Circulation; Oxidation-Reduction; Pyridines

1990
Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:10

    Topics: Adult; Antipyrine; Diltiazem; Half-Life; Humans; Indocyanine Green; Labetalol; Male; Random Allocation; Verapamil

1989
Dose dependent effect of diltiazem on the pharmacokinetics of nifedipine.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:11

    Topics: Adult; Chromatography, Gas; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Humans; Indocyanine Green; Male; Nifedipine; Pyridines

1989
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:2

    Topics: Adult; Antipyrine; Benzazepines; Biological Availability; Diltiazem; Drug Interactions; Female; Humans; Indocyanine Green; Kinetics; Liver; Male; Metabolic Clearance Rate; Nifedipine; Random Allocation; Verapamil

1986

Other Studies

4 other study(ies) available for diltiazem and indocyanine green

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Protective effect of PGI2 and diltiazem on liver ischemia and reperfusion in pigs.
    Transplantation proceedings, 1988, Volume: 20, Issue:5

    Topics: Ammonia; Animals; Blood Flow Velocity; Body Water; Diltiazem; Epoprostenol; Indocyanine Green; Ischemia; Liver; Reperfusion Injury; Swine

1988
No effect of diltiazem on the hepatic clearance of indocyanine green in the rats.
    Archives of pharmacal research, 1998, Volume: 21, Issue:4

    Topics: Animals; Blood Proteins; Coloring Agents; Diltiazem; Dose-Response Relationship, Drug; Indocyanine Green; Liver Function Tests; Male; Metabolic Clearance Rate; Protein Binding; Rats; Rats, Sprague-Dawley

1998